ICD-10-CM Billable Code

D31.60

Benign neoplasm of unspecified site of unspecified orbit

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign neoplasm of the orbit refers to a non-cancerous growth that develops in or around the eye socket, known as the orbit. When the exact location within the orbit isn't specified, and the tumor is non-malignant, it is classified under ICD-10 code D31.60. Though benign, these growths can affect eye function and appearance, making understanding their nature and management important.

Causes & Symptoms

Clinical Causes: Genetic factors: Certain inherited traits can predispose individuals to develop benign tumors in the orbital area. Unknown factors: In many cases, the exact cause of orbital neoplasms remains unidentified. Developmental anomalies: Abnormal tissue growth can sometimes lead to benign tumors in the orbit. Previous radiation exposure: A history of radiation treatment in the head or face might increase risk. Environmental influences: Though less clear, environmental factors may play a minor role in tumor development.

Key Symptoms: Visible swelling or lump in the eyelid or orbit Protrusion or bulging of the eye (proptosis) Changes in vision or visual disturbances Pain or discomfort around the eye area Difficulty moving the eye or double vision A sensation of fullness or pressure in the orbit Asymmetry of the eye or facial features in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing a benign orbital neoplasm involves multiple steps to accurately identify the nature and location of the tumor: - Clinical examination: A healthcare provider assesses the eye, eyelids, and surrounding tissues for swelling, protrusion, or other abnormalities. - Imaging tests: - Magnetic Resonance Imaging (MRI): Offers detailed pictures of soft tissues and helps determine the exact size and location of the tumor. - Computed Tomography (CT) scan: Useful for assessing bone involvement and delineating tumor boundaries. - Biopsy: In rare cases, a tissue sample may be taken to confirm the benign nature of the growth and rule out malignancy. - Visual assessments: Tests to evaluate any impact on vision or eye movement. These diagnostic approaches help ensure accurate identification and planning for appropriate management.

Treatment Protocols: Management of a benign orbital neoplasm depends on its size, location, symptoms, and potential impact on vision or eye function: - Observation: Small, asymptomatic tumors may be monitored periodically without immediate intervention. - Surgical removal: Indicated when the tumor causes symptoms, cosmetic concerns, or has potential for growth. The goal is complete excision while preserving eye function. - Other therapies: In rare cases, additional treatments such as corticosteroids might be used to reduce inflammation if present. - Follow-up care: Regular post-treatment evaluations are essential to monitor for recurrence or complications. Since each case is unique, a multidisciplinary approach involving ophthalmologists, radiologists, and surgeons often provides optimal results.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D31.60 a billable ICD-10 code?
Yes, D31.60 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D31.60?
Clinical documentation must specify the nature of Benign neoplasm of unspecified site of unspecified orbit and any associated comorbidities for accurate reporting.

Cite this Clinical Reference